Trial Profile
Randomized, double-blinded, placebo-controlled multicentre trial studying healing effect of rebamipide in patients with low-dose aspirin and/or NSAID induced small bowel injury
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Oct 2015
Price :
$35
*
At a glance
- Drugs Rebamipide (Primary)
- Indications NSAID-induced gastrointestinal damage
- Focus Therapeutic Use
- 13 Oct 2015 New source identified and integrated.
- 13 Oct 2015 New trial record